EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression

Paolo Alonge iD, Carmela Rita Balistreri iD, Angelo Torrente iD, Daniele Magro iD, Elisa Rubino, Roberto Monastero iD

Brain Sciences · 05.04.2025 · 15 (4) · 379

DOI: 10.3390/brainsci15040379 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 05.04.2025. Verfasst von Paolo Alonge und 5 weiteren Autor:innen. Beteiligte Einrichtung: Memory and Parkinson's Disease Center, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Via La Logg…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The activation of microglia and the activity of innate immunity have recently been recognized as part of Parkinson’s Disease (PD) pathophysiology. Triggering receptor expressed on myeloid cells 2 (TREM2) is a gene with neuroprotective roles. Its variations are associated with microglial-associated neurodegeneration. The objective of the present review is to investigate the current evidence on the role of TREM2 in PD pathophysiology.

Methods

A comprehensive search was performed using PubMed, Medline, and Web of Science, looking for English papers investigating the role of TREM2 in PD, or more in general, the genetic profile of microglia.

Results

Thirty-one papers were considered relevant. Preclinical studies with PD models showed some contradictory results, even if a loss of function of TREM2 is generally associated with a microglial activation in α-synuclein-induced inflammatory processes. The role for TREM2 genetic variations in PD patients should be taken with even more caution. The increase in the soluble extracellular segment of TREM2 (sTREM2) in cerebrospinal fluid of PD patients seems to be associated with increased risk of cognitive decline.

Conclusions

There is increasing evidence that TREM2 may have an important role in PD pathophysiology as demonstrated by preclinical and clinical studies. Further investigations are needed to confirm this role and may lead the way for future targeted therapies for different neurodegenerative disorders.

Schlagwörter

Stichwörter der Autor:innen

PDParkinson’s diseaseTREM2microglianeurodegenerative disordersneuroinflammation

Autor:innen und Institutionen

  • Memory and Parkinson's Disease Center, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, Via La Loggia 1, 90129 Palermo, Italy.
  • Cellular and Molecular Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90134 Palermo, Italy.

ORCID-Profile: Paolo Alonge, Carmela Rita Balistreri, Angelo Torrente, Daniele Magro, Roberto Monastero

Zitieren

APA

Alonge, P., Balistreri, C. R., Torrente, A., Magro, D., Rubino, E., & Monastero, R. (2025). TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression. Brain Sciences, 15(4), 379. https://doi.org/10.3390/brainsci15040379

Vancouver

Alonge P, Balistreri CR, Torrente A, Magro D, Rubino E, Monastero R. TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression. Brain Sciences. 2025;15(4):379. doi:10.3390/brainsci15040379

BibTeX
@article{Alonge2025,
  author = {Alonge, Paolo and Balistreri, Carmela Rita and Torrente, Angelo and Magro, Daniele and Rubino, Elisa and Monastero, Roberto},
  title = {TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression},
  journal = {Brain Sciences},
  year = {2025},
  volume = {15},
  number = {4},
  pages = {379},
  doi = {10.3390/brainsci15040379}
}
Kostenlos starten →